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Rheumatoid factor (RF) 1 autoantibodies against autoiogous IgG are found in 
the  sera  of most  patients  with  rheumatoid  arthritis  (RA)  (1).  IgM-RF,  and 
particularly  IgG-RF comprise a  large  part  of the  immune  complexes that  are 
abundant  in  rheumatoid  synovial  fluid,  and  may  contribute  to  complement 
consumption and chronic tissue damage (2). 
RF are not specific for RA. The autoantibodies have been detected in the sera 
of some normal  individuals  (3) and  in  the culture  supernatants  of polyclonally 
activated normal lymphocytes (4). IgM-RF autoantibodies are produced regularly 
during primary and secondary immune responses in humans and mice (5-7). In 
a  well-defined  murine  system,  IgM-RF  synthesis  was  dependent  upon  both 
immune  spleen  cells  and  the  relevant  antibody  (8,  9).  These  results  strongly 
suggest that IgM-RF are a physiologic component of the immune system (7,  10). 
Conceivably, antibodies with evolutionarily significant protective or regulatory 
functions  may  be encoded by germ  line  V,  and  VL (variable  heavy and  light 
chains) genes.  Crossreactive idiotypes (CRI) represent serologic markers for Ig 
V. and VL sequences.  In elegant studies,  Kunkel and coworkers (11) described 
two CRI, (Wa and Po), on Waldenstrom's macroglobulins with IgM-RF activity. 
The  mutually exclusive Wa and  Po CRI were expressed,  respectively, by 65% 
and 20% of monoclonal IgM-RF. Amino acid sequence analyses (12, 13) revealed 
that  Wa-CRI + IgM-RF have similar  L  chains,  and  that  Po-CRI + proteins  have 
similar H  chains. 
To gain insight concerning structural and genetic relationships among a larger 
series of IgM-RF proteins in an  outbred human  population,  we generated  two 
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different  antiidiotypic  antibodies  against  short,  primary  sequence-dependent 
idiotypic determinants on RF H and L chains (14,  15).  In initial experiments, an 
antiidiotypic  antibody  was  induced  by immunization  with  a  synthetic  peptide 
corresponding  to  the  H  chain  third  hypervariable  region  (complementarity 
determining  region) (CDR) of the Wa-CRI  + IgM-RF Sie.  The antipeptide anti- 
body reacted with the Sie protein, but not with pooled human  Ig. A subsequent 
antiidiotype, produced by immunization  with a synthetic peptide corresponding 
to the second CDR of the IgM-RF Sie L chain, recognized  10 out of 12 human 
IgM-RF paraproteins  (15,  16).  The latter results suggested that the majority of 
IgM-RF L chains are encoded by a single germline Vk gene, or a family of closely 
related Vk genes (16). 
In the present experiments,  the CDR structures on RF H  and  L chains have 
been  probed  with  seven  different  peptide-induced  antiidiotypic  antibodies.  A 
panel of 16 human  monoclonal  IgM-RF was screened by immunoblotting  with 
the  antipeptide  antibodies.  The  results  show that  the  majority of RF share  at 
least two L chain-associated  CRI, but not H  chain-associated idiotypes. Appar- 
ently, antibodies with anti-IgG autoantibody activity repeatedly utilize a common 
K L  chain  sequence, but diverse H  chain  sequences.  Thus,  in contrast  to the  L 
chains, RF H  chains may employ a large number of V. genes. 
Materials and Methods 
Preparation of  Synthetic Peptides and Antipeptide Antibodies.  The seven synthetic peptides 
listed in Table I (17-19) were prepared by Merrifield's (20) solid-phase method, slightly 
modified as previously described (14,  15,  20,  21).  Each peptide (P) was assigned a  four- 
letter code, designating the corresponding parental protein (S, W, P), heavy or light chain 
(H, L), and complementarity determining region (1-3). The peptides were conjugated via 
cysteine to keyhole limpet hemocyanin (KLH) with m-maleimidobenzoyl N-hydroxysuccin- 
amide ester (22).  In initial experiments, rabbits were immunized twice with conjugates 
emulsified in complete Freund's adjuvant (CFA), then boosted twice with glutaraldehyde- 
TABLE  I 
Amino Acid Sequences of the Synthetic Peptides 
Peptide  Protein  Residues  name*  spanned*  Amino acid sequence  § 
PSL2  Sie  49-61 
PSL3  Sie  88-99 
PSH2  Sie  49-65 
PSH3  Sie  95-102 
PWH2  Wol  49-65 
PWH3  Wol  95-102 
PPH2  Pore  49-65 
PPH3  Pore  95-102 
YGASSRATGIPDR(C) 
CQQYGSSPQTFG 
GSPAKWTDPFQGVYIKWE(GGC) 
EWKGQVNVNPFDY(GGC) 
GQIPLRFNGEVKNPGSVV(GGC) 
EYGFDTSDYYYYY(GGC) 
AWKYENGNDKHYADSVNG(GGC) 
DAGPYVSPTFFAH(GGC) 
* The first letter, P, designates the peptide, the second letter designates the correspond- 
ing parent protein, the third letter designates the heavy or light chain, and the fourth 
letter designates the CDR. 
* Numbered according to Kabat et al. (17). 
§ The amino acid sequences were reported previously (13,  18,  19). The underlined 
residues belong to the adjacent framework regions (FR).  The  residues within the 
parentheses were added to  the  C-terminus for coupling purposes. The  one-letter 
amino acid code is used. CHEN ET  AL.  489 
crosslinked peptides in incomplete adjuvant, as described previously (14, 15). Thereafter, 
antisera were obtained and characterized. Subsequently, the immunization procedure was 
changed to two injections of conjugates in CFA at 1-mo intervals. This scheme generated 
antibodies with the same specificity as the original protocol. 
Preparation of Proteins.  Plasma  or purified proteins from patients with  monoclonal 
IgM cryoglobulins were generously provided by Drs. J.  D.  Capra (University of Texas 
Southwestern Medical School, Dallas,  TX) G. Abraham (University of Rochester School 
of Medicine,  Rochester, NY) J. Johnson (Nashville, TN) D.  Normansell (University of 
Virginia, Charlottesville, VA) and H. Metzger (National Institutes of Health, Bethesda, 
MD). The IgM cryoglobulins were purified by repeated precipitation at 4°C, followed by 
chromatography on Sephadex G-200 in 0.1  M acetic acid (23), or Ultrogel AcA 22 in 0.2 
M  sodium  acetate, pH  3.5.  Pooled human  IgG was  prepared from Cohn  Fraction  II 
(Sigma  Chemical  Co.,  St.  Louis,  MO)  by  DEAE-cellulose chromatography in  0.01  M 
sodium phosphate,  pH  8.0.  Bence-Jones K L  chains, prepared from patients'  urine by 
ammonium sulfate precipitation, were the generous gift of Dr. Elliott Osserman (Columbia 
University College of Physicians and  Surgeons,  New  York).  The  K subgroups  of the 
various L chains were kindly determined by Dr. Alan Solomon (University of Tennessee, 
Knoxville, TN) using subgroup-specific antisera (24). 
Enzyme-linked Immunosorbent Assay (ELISA).  The ELISA method for idiotype detection 
has been described previously (14,  15). Briefly, antigens in borate-buffered saline (BBS), 
0.1  M borate, 0.2  M NaCI, pH 8.2, were used to coat microtiter plates at  100 ~l/well. 
After blocking with  1% bovine serum albumin (BSA),  100 ~1 of samples diluted in BBS 
containing 0.5% BSA were distributed to duplicate wells. The plates were incubated for 
3 h at room temperature, and the bound antibodies were quantified by the binding of 
human IgG-adsorbed, alkaline phosphatase-labeled goat anti-rabbit IgG antibodies (Kir- 
kegaard and Perry, Gaithersburg, MD). 
Immunoblotting.  The reactivities ofantipeptide antibodies with Ig L and H chains were 
analyzed by the Western blot method (25), with some modifications (14, 16, 26).  Briefly, 
20 ~g of each individual protein (13, 23) or pooled human IgG in gel buffer were loaded 
onto each slot of a  10% polyacrylamide slab gel containing 0.1% sodium dodecyl sulfate 
(27).  After electrophoresis (2.5  h  at  30  mA),  the proteins in the gel were transferred 
electrophoretically to nitrocellulose papers (2  h  at  70  V).  Protein-binding sites  on the 
papers were quenched with 0.01  M phosphate-buffered saline, pH  7.2, containing 5% 
BSA  for  1 h  at  room  temperature.  Subsequently, the  papers  were  overlaid with  the 
indicated antisera in BBS for 1 h.  After washing with BBS, the papers were incubated 
with v"~I-labeled protein A (1 mCi/mg, 2 x  10 ~ cpm/ml) for another hour. Then, papers 
were washed with  BBS,  dried, and finally exposed to Kodak XAR-5 film overnight at 
-70°C. 
Results 
Expression of Two Major CRI on Human IgM-RF L Chains.  All rabbits produced 
high titers (1:10,000) of antipeptide antibodies, as measured by ELISA (data not 
shown).  Depending  upon  the  immunizing  peptide,  approximately  half of the 
animals produced antibodies that reacted with the  L  or H  chains of the parent 
protein,  as  assessed  by  immunoblotting.  These  latter  antibodies  were  used  to 
analyze idiotypic crossreactions among multiple IgM-RF. 
Previously, we  showed  that  10  out of 12  (83%)  human  monoclonal  IgM-RF 
bear the  PSL2-associated CRI  marker (16) (Table II).  Subsequently, five addi- 
tional  IgM-RF  were analyzed for the  PSL2-CRI.  Fig.  1 a (left) shows that anti- 
PSL2 antibodies react with three out of these five new IgM-RF.  Together with 
our  previous  data,  13  out  of  17  (76%)  IgM-RF  express  the  PSL2-CRI.  This 
figure is  close to  the  65%  of IgM-RF  that  express the  Wa-CRI  (11,  28).  The 490  1DIOTYPES  OF  HUMAN  RHEUMATOID  FACTOR 
TABLE  II 
Idiotype Expression of 17 Human Monoclonal IgM-RF 
IgM-RF  PSL2*  PSL3*  PSH3  PWH2  PWH3  PPH2  PPH3 
Cur  ++  ++  ..... 
Gar  ++  ++  ..... 
G]o  ++  ++  ..... 
Got  ++  ++  ..... 
Neu  ++  +  ..... 
Pal  ++  ++  -  ND ~  ND  ND  ND 
Pay  ++  ++  ..... 
Pore  .....  ++  ++ 
Sie  ++  ++  ++  .... 
Wol  ++  --  --  ++  ++  --  -- 
Boc  ++  ++  ..... 
Fin  ++  ++  ..... 
Gal  -  ++  +  .... 
Lew  ++  ...... 
She  ....... 
Lay  -  -  -  ND  ND  -  - 
Teh  ++  ND  -  ND  ND  ND  ND 
Total positive  13  11  2  1  1  1  1 
Total assayed  17  16  17  14  14  15  15 
Percent positive  76  69  12  7  7  7  7 
*  The  results of five RF are in Fig.  1 a.  The other results are from Chen et al. (16). 
*  Data  oil first nine RF are from  F.  G6ni,  P.  P.  Chen,  B.  Pons-Estel,  D. A. Carson, and B. Frangione. 
1985.  Preferential  VK  and  JK  utilization in  human monoclonal IgM  autoantibodies (rheumatoid 
factors). Manuscript in preparation. 
§ ND,  not done. 
results lend further support to the possibility that the second CDR on RF light 
chains (L2) is the structural correlate of the Wa-CRI. 
It remains controversial whether somatic mutations in Ig variable regions are 
linked to the Ig class  switch (29-31),  or whether they occur commonly in IgM 
molecules (32-34).  The IgM-RF  L chains, which bear the PSL2-CRI, are likely 
encoded  by  a  single  Vk  gene  or a  family of closely  related  Vk  genes  (16).  To 
estimate  the  extent  of diversification  of PSL2 +  RF  L  chains,  antibodies  were 
generated against the third CDR of the IgM-RF Sie K  chain (PSL3). Immunoblot- 
ting with the  two antipeptide  antibodies  enabled  us to determine  whether the 
anti-PSL2-  and  anti-PSL3-defined  sequences  cosegregated  among  a  panel  of 
IgM-RF proteins from unrelated individuals. 
Three rabbits  were immunized  with the  PSL3  peptide  conjugated  to  KLH. 
One rabbit antisera  reacted  well with isolated Sie L chains and with the intact 
IgM-RF Sie protein (Table III  and Fig. 2).  Antibody binding to both intact Sie, 
and to Sie L chains was inhibited by the free PSL3 peptide (data  not shown). 
The reactivity of the anti-PSL3  antibody against a panel of 16 human  mono- 
clonal  IgM-RF  was analyzed  by  immunoblotting.  As shown in  Fig.  2,  the anti- 
PSL3  bound  to only two out of three  known Wa-CRI + RF,  indicating that  the 
third CDR of the  L chain  is unlikely to be the structural  basis  of the Wa-CRI. 
Fig.  I b  (right)  and  Fig.  3 show that anti-PSL3  reacts with three additional  RF, 
but with none of six t¢ Bence-Jones proteins. Among these six L chains, Eps and CHEN  ET  AL.  491 
FIGURE  1.  Immunoblot analysis of the anti-PSL2 (at 1:500 dilution) and anti-PSL3 (at 1:50 
dilution) antisera. About 20 ~tg of each IgM-RF paraprotein (except Ga 1 10 ~tg) was loaded in 
each  lane.  After electrophoresis  and transfer of samples, the papers  were reacted with the 
indicated antisera,  developed  with radiolabeled  protein A, and finally exposed to XAR film 
overnight. Protein Ga I is the abbreviation of Ga 1  v. 
TABLE  III 
ELISA  of Anti-PSL3,  Anti-PPH2,  and Anti-PPH3 Antisera 
Exp. 
Antigens (A4o5 Y lOS)  * 
Antisera  BSA  Peptide  RF 
1  Anti-PSL3  3  836  309 
NRS  7  26  151 
Anti-PPH2  3  901  66 
Anti-PPH3  10  1,052  181 
NRS  0  1  26 
Buffer  9  15  13 
* Antigens were used at 2 #g/ml, and antisera were used at 1  : 100 dilution. 
Wie belong to the K I  subgroup, Mcg belongs to the K II subgroup, and the vest 
belong to the KIII subgroup. Thus, the anti-PSL3 defines a  primary sequence- 
dependent  CRI  that  is  expressed  by  69%  of IgM-RF paraproteins (Table  II). 
Furthermore, the PSL2- and PSL3-defined CRI are often found together on the 
same L  chain. 
Expression  of  Three  H  Chain  Idiotypes  Associated  with  Two  Wa-CRI  +  IgM 492  IDIOTYPES  OF  HUMAN  RHEUMATOID  FACTOR 
FmtJRE  2.  lmmunoblot analysis of RF  bearing either  the  Wa-CRI  or  the  Po-CRI.  The 
experiment was performed as described in  Fig.  1, except that only 8 tzg of Wol was loaded, 
and that polyspecific rabbit anti-human lg antibodies (IgG fraction, at 5 #g/ml) were used to 
show the relative amount of polypeptides blotted onto nitrocellulose paper. 
RF.  Synthetic peptide-induced antibodies and immunoblotting were used sim- 
ilarly  to study the  idiotypes associated  with  RF  H  chains.  Four  peptides  were 
synthesized, corresponding to the second and third H chain CDR of the IgM-RF 
Sie and Wol. These two proteins express the dominant Wa-CRI. Antisera from 
PSH2-immunized  rabbits  reacted  with  the  free  peptide,  but  not  with  Sie  H 
chains.  In contrast,  anti-PSH3  from all four immunized  rabbits reacted specifi- 
cally with the intact IgM-RF Sie, and with isolated Sie H  chains (14),  Fig. 4 and 
Fig.  5c (lower  left).  17  different  IgM-RF were probed  with  the  PSH3-induced 
antiidiotype.  Only one RF, other than Sie, was weakly positive. 
Both the PWH2 and PWH3 peptides induced rabbit antibodies that recognized 
the isolated  H  chains  of IgM-RF Wol.  Fig.  5 d  (lower  right),  and  Figs.  6  and  7 
show  that  only  Wol  is  positive  for  the  PWH2- and  PWH3-defined  idiotypes, 
among  14 IgM-RF analyzed. 
Expression  of Two H  Chain Idiotypes Associated with Po-CRI + RF.  The Po-CRI 
antigen is present on 20% of human monoclonal IgM-RF (I 1). Po-CRI  + IgM-RF 
have similar  VH sequences (13),  particularly  in  the second and  third  CDR (H2 
and H3). Peptides corresponding to the H2 and H3 regions of the IgM-RF Pore CHEN  ET  AL.  493 
FIGURE  3.  Immunoblot analysis of six Bence-Jones r  L chain proteins. The methods are the 
same as in Fig. 2.  Protein  Mcg is the abbreviation of McGee. 
FIGURE  4.  Immunoblot analysis of the anti-PSH3  antiserum. The methods are the same as 
in Fig.  1. 494  ID1OTYPES  OF  HUMAN  RHEUMATOID  FACTOR 
FIGURE  5.  Immunoblot analysis of six  IgM-RF with four different peptide-induced antiidi- 
otypic antisera,  The  experiments were performed as in  Fig.  1,  except that the papers were 
reacted first with either anti-PPH2  (a) or anti-PPH3  (b), and then with either anti-PSH3  (c) 
or anti-PWH3 (d). This modification was necessitated by the very limited supply of these IgM- 
RF. CHEN  ET  AL.  495 
FIGURE 6.  lmmunoblot analysis of 14  IgM-RF with the anti-PWH2 (at 1:10 dilution) anti- 
serum. The protocol was the same as in Fig. 1, except that phosphate buffered saline was used 
through the whole experiment. 
FIGURE  7.  hnmunoblot analysis of nine [gM-RF with the anti-PWH3 antiserum. The meth- 
ods are the same as in Fig.  1. 
were synthesized (Table I) and  used to immunize  rabbits. All PPH3-immunized 
rabbits, and one of two  PPH2-immunized  rabbits, produced  antibodies reactive 
with  the  parent  protein  Pore  (Table  III).  Fig.  5  (a and  b, top) and  Fig.  8  show 496  IDIOTYPES  OF  HUMAN  RHEUMATOID  FACTOR 
FtC.URE  8.  lmmunoblot analysis of nine  IgM-RF with the indicated antisera.  The  methods 
are the same as in Fig.  1. 
that anti-PPH2 and anti-PPH3  antibodies reacted well with Pom H  chains,  but 
not with the other RF analyzed. 
Discussion 
Synthetic peptides were used to generate seven specific antiidiotypic antibodies 
against human IgM-RF. These reagents were tested against a large panel of IgM- 
RF paraproteins.  The  results  demonstrate  that  the  majority  of human  mono- 
clonal IgM-RF share two primary sequence-dependent CRI, corresponding the 
second  CDR and  third  CDR of the  K L  chain.  An  analysis  of the  amino  acid 
sequences of four RF expressing both the PSL2- and  PSL3-CRI revealed com- 
plete identity in the whole Vk gene region (35). In addition,  five RF bearing the 
PSL2-CRI have almost identical sequences, with only one to four different amino 
acid residues per RF L chain (12). 
In contrast to the recurrent  CRI on  IgM-RF L  chains,  the H  chain  idiotypes 
are extremely private.  Thus, all of four antiidiotypes against synthetic peptides, 
corresponding tO different H  chain CDR, reacted only with the parent proteins. 
A fifth peptide-induced antiidiotype reacted weakly with one additional IgM-RF. 
These  results  suggest  either  that  RF  H  chains  are  encoded  by a  number  of 
different VH and  D. (diversity regions of H  chain of Ig) genes, or that  IgM-RF 
H  chain  sequences reflect  an  unusually  high  degree  of somatic  mutation  in  a 
limited  number  of  VH  genes,  as  well  significant  variation  in  VDJ  (variable, 
diversity, joining region) gene joining. 
Crossreactive idiotypes represent phenotypic markers for V. and VL genes (36, CHEN  ET  AL.  497 
37). For L chains, the VL genes encode amino acid residues up to about position 
95 (i.e. including 2/3 of CDR3 region) (38, 39). The V, genes encode amino acid 
residues  up  to  about  position  94,  the  last  amino  acid  residue  of the  third 
framework region. The third CDR of H  chains (H3) is encoded by DH, J., and 
nucleotides of unknown origin (40-42). Only 5-10 DH genes, and five J. genes, 
have been identified in humans and mice. However, imprecise joining at the VD 
and DJjunctions together with the inclusion of other nucleotides, make the third 
H  chain hypervariable region the most heterogeneous among the six  Ig CDR 
(42-44). This conclusion was demonstrated elegantly by primary sequence anal- 
ysis of eight murine IgM antigalactan antibodies (45, 46). Thus, it is not surprising 
that all three antibodies against synthetic peptides, corresponding to the third 
CDR of RF H chains, recognized private idiotypes. 
We anticipated that antibodies against one or both synthetic peptides, repre- 
senting the second CDR of IgM-RF H  chains, would recognize a CRI determi- 
nant.  In  the  IgM  antigalactan  system,  the  second  CDR  of the  H  chain  was 
identical in seven out of eight cases (45).  The eight H  chains were all encoded 
by a single VH gene (34), and four had identical amino acid sequences through 
the whole variable region.  Seven of the  IgM antigalactan antibodies also had 
identical sequences through the whole VK region (46). By analogy, the fact that 
the monoclonal IgM-RF H  chain-associated idiotypes were unique among 14- 
15 different RF strongly suggests that the autoantibodies employ a  number of 
different V, genes. 
In conclusion, the synthetic CDR peptide-induced antiidiotypes reveal that 
70%  of monoclonal human  IgM-RF share two light chain-associated CRI.  In 
contradistinction, all five H chain CDR-associated idiotypes were private, among 
14-17 monoclonal IgM-RF analyzed. Together, these results establish that the 
majority of IgM-RF share homologous VL, but have heterogeneous V,. It seems 
likely that one (or very few) VL genes, but a larger number of VH genes, are used 
to encode IgM-RF autoantibodies. 
Summary 
Recently, we have used synthetic peptides corresponding to the complemen- 
tarity-determining regions (CDR) of Ig molecules to induce antiidiotypic antisera. 
Peptide PSH3, representing the third CDR of the IgM rheumatoid factor (RF) 
Sie heavy (H) chain, induced a private antiidiotype that reacted with only one 
out of five IgM-RF. Peptide PSL2, corresponding to the second CDR of Sie light 
(L) chain, induced an antibody against a crossreactive idiotype (CRI), expressed 
by 10 out of 12 human IgM-RF analyzed. Herein, we report that five additional 
antiidiotypic antibodies were generated by immunization with synthetic peptides 
identical to the third L chain CDR of IgM-RF Sie (PSL3), the second and third 
H  chain CDR of IgM-RF Wol, and the second and third CDR of IgM-RF Pore. 
As analyzed by immunoblot assay, both anti-PSL3 and anti-PSL2  reacted with 
the majority of 16  IgM-RF. In contrast, all five antiidiotypes induced by the H 
chain peptides reacted only with the parent proteins, except anti-PSH3, which 
reacted weakly with one additional RF. These results suggest that one (or very 
few) VL gene(s), but a  larger number of VH genes, are used to encode IgM-RF 
autoantibodies. 498  IDIOTYPES OF  HUMAN  RHEUMATOID  FACTOR 
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